Summary
Effecs of drugs which enhance or reduce GABAergic neurotransmission upon conflict behavior were evaluated with a modified Vogel procedure which was shown to be insensitive to variations in motivation to drink and to the analgesic effects of morphine. In addition, the effects of these drugs on ambulatory activity and motor execution were quantified. For comparison, the benzodiazepines diazepam and chlordiazepoxide were used. Anticonflict actions of diazepam were obtained with a shock current of 0.25 mA but not with 0.05 or 0.5 mA, whereas the proconflict effect of FG7142 was obtained with 0.05 mA but not with higher currents. Diazepam and chlordiazepoxide had anxiolytic effect in a dose similar to that required to reduce ambulatory activity, but below that needed to affect motor execution. At doses high enough to impair motor execution, anticonflict effects were considerable. The GABA-A receptor agonist THIP and the GABA-B receptor agonist baclofen lacked effect on conflict behavior in moderate doses, which reduced ambulatory activity. In doses which produced motor deficiencies these drugs reduced licking both in the conflict test and when tested without shock administration. The effects of the GABA transaminase inhibitors 7-acetylen GABA and sodium valproate were similar to those of the receptor agonists. The GABA reuptake inhibitor SKF 100330A produced anticonflict effect in a dose below that needed to reduce ambulatory activity, but lacked effect on conflict behavior in higher doses. The GABA antagonist picrotoxin, and the GABA synthesis inhibitors 4-deoxypyridoxine and isoniazide, reduced licking both in the absence and presence of shock, and affected motor functions in the same doses. Bicuculline, at the doses used, had no behavioral effects. The different behavioral profiles of GABAergic agents and benzodiazepines, and the lack of consistent effects of the former on conflict behavior, seem to suggest that GABA receptors are not involved in conflict reduction. Further evidence for this hypothesis was obtained in experiments where it was found that the GABA antagonists bicuculline and picrotoxin did not block the effects of the benzodiazepines. No evidence was found for a tonic anticonflict action of GABAergic systems. It thus appears that anticonflict actions of benzodiazepines may be independent of GABAergic mechanisms.
Similar content being viewed by others
References
Ågmo A, Fernandez H (1991) Benzodiazepine receptor ligands and sexual behaviour in the male rat: The role of GABAergic mechanisms. Pharmacol Biochem Behav 38:781–788
Ågmo A, Giordano M (1985) The locomotor-reducing effects of GABAergic drugs do not depend on the GABA-A receptor. Psychopharmacology 87:51–54
Ågmo A, Paredes R, Fernandez H (1987) Differential effects of GABA transaminase inhibitors on sexual behavior, locomotor activity, and motor execution. Pharmacol Biochem Behav 28:47–52
Allikmets LH,Rägo LK (1983) The effect of benzodiazepine antagonist Ro 15–1788 on the effects of GABAergic drugs. NaunynSchmiedeberg's Arch Pharmacol 324:235–237
Baraldi M, Grandison L, Guidotti A (1979) Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology 18:57–62
Braestrup C, Honore T, Nielsen M, Petersen EN, Jensen LH (1983) Benzodiazepine receptor ligands with negative efficacy: Chloride channel coupling. In: Biggio G, Costa E (eds) Benzodiazepine recognition site ligands: Biochemistry and pharmacology: Raven, New York, pp 29–36
Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC (1982) Mechanism of anticonvulsant action of valproate. Prog Neurobiol 19:315–359
Cook L, Sepinwall J (1980) Relationship of anticonflict activity of benzodiazepine to brain receptor binding, serotonin, and GABA. Psychopharmacol Bull 16:30–32
Cooper SJ (1982) Benzodiazepine mechanisms and drinking in the water-deprived rat. Neuropharmacology 21:775–780
Corda MG, Blaker WD, Mendelson WB, Guidotti A (1983) \-carbolines enhance shock-induced suppression of drinking in rats. Proc Natl Acad Sci USA 80:2072–2076
Enna SJ, Maggi A (1979) Biochemical pharmacology of GABAergic agonists. Life Sci 24:1727–1738
Enna SJ, Möhler H (1987) γ-aminobutyric acid (GABA) receptors and their association with benzodiazepine binding sites. In: Meltzer HY (ed) Psychopharmacology: The third generation of progress. Raven, New York, pp 265–272
File S (1982) Chlordiazepoxide-induced ataxia, muscle relaxation and sedation in the rat: Effects of muscimol, picrotoxin and naloxone. harmacol Biochem Behav 17:1165–1170
Fonnum F (1987) Biochemistry, anatomy, and pharmacology of GABA neurons. In: Meltzer HY (ed) Psychopharmacology: The third generation of progress. Raven, New York, pp 173–182
Gardner CR, Piper DC (1982) Effects of agents which enhance GABA-mediated neurotransmission on licking conflict in rats and exploration in mice. Eur J Pharmacol 83:25–33
Gray JA, Quintero S, Mellanby J, Buckland C, Fillenz M, Frang SC (1984) Some biochemical, behavioural, and electrophysiological tests of the GABA hypothesis of anti-anxiety drug action. In: Bowery NG (ed) Actions and interactions of GABA and benzodiazepine. Raven, New York, pp 239–262
Guidotti A, Corda MG, Wise BC, Vaccarino F, Costa E (1983) GABAergic synapses: Supramolecular organization and biochemical regulation. Neuropharmacology 22:1471–1479
Johnston GAR (1986) Multiplicity of GABA receptors. In: Olsen RW, Venter J (eds) Benzodiazepine/GABA receptors and chloride channels: Structural and functional properties. Alan R. Liss, New York, pp 57–71
Johnston GAR, Skerritt JH (1984) GABARINS and the nexus between GABA and benzodiazepine receptors. In: Bowery NG (ed) Actions and interactions of GABA and benzodiazepines. Raven, New York, pp 179–189
Jung MJ, Lippert B, Metcalf BW, Schechter PJ; Bohler P, Sjoerdsma A (1977) The effect of 4-amino hex-5-ynoic acid (γ-acetylenic GABA, γ-ethynyl GABA), a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo. J Neurochem 28:717–723
Ketelaars CEJ, Bollen EL, Rigter H, Bruinvels J (1988) GABA-B receptor activation and conflict behavior. Life Sci 42:933–942
Krogsgaard-Lassen P, Nielsen L, Falch E, Brehm L, Jörgensen FS (1988) Molecular pharmacology of GABA and GABA synaptic mechanisms. In: Lunt GG (ed) Neurotox' 88: Molecular basis of drug and pesticide action. Elsevier, Amsterdam, pp 145–155
Liljequist S, Engel JA (1984) Reversal of the anticonflict action of valproate by various GABA and benzodiazepine antagonists. Life Sci 34:2525–2533
Lindgren S, Anden NE (1984) On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA. Acta pharmacol toxicol 55:41–49
Löscher W, Vetter M (1984) Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlations to pharmacological effects. Neurosci Lett 47:325–331
McCabe RT, Wamsley JK (1986) Autoradiographic localization of subcomponents of the macromolecular GABA receptor complex. Life Sci 39:1937–1945
Olsen RW (1982) Drug interactions at the GABA receptor-ionophore complex. Ann Rev Pharmacol Toxicol 22:245–277
Paredes R, Ågmo A (1989) Stereospecific actions of baclofen on sociosexual behavior, locomotor activity and motor execution. Psychopharmacology 97:358–364
Pellow S, File SE (1984) Multiple sites of action for anxiogenic drugs: Behavioural, electrophysiological and biochemical correlations. Psychopharmacology 83:304–315
Petersen EN, Buns Lassen J (1981) A water conflict paradigm using drug experienced rats. Psychopharmacology 75:236–239
Petersen EN, Jensen LH (1984) Proconflict effect of benzodiazepine inverse agonists and other inhibitors of GABA function. Eur J Pharmacol 103:91–97
Pollard GT, Howard JL (1990) Effects of drugs on punished behavior: Pre-clinical test for anxiolytics. Pharmacol Ther 45:403–424
Quintero S, Henney S, Lawson P, Mellanby J, Gray JA (1985) The effects of compounds related to y-aminobutyrate and benzodiazepine receptors on behavioral responses to anxiogenic stimuli in the rat: Punished barpressing. Psychopharmacology 85:244–251
Rägo L, Kiivet RA, Harro J (1986) Variation in behavioral response to baclofen: Correlation with benzodiazepine binding sites in mouse forebrain. Naunyn-Schmiedeberg's Arch Pharmacol 333:303 -306
Rasmussen KJ, Schneider HH; Petersen EN (1981) Sodium valproate exerts anti-conflict activity in rats without any concomitant rise in forebrain GABA level. Life Sci 29: 2163–2170
Richards JG, Möhler H (1984) Benzodiazepine receptors. Neuropharmacology 23:233–242
Rodgers RJ, Randall JI (1987) Benzodiazepine ligands, nociception and defect analgesia in male mice. Psychopharmacology 91:305–315
Sanger DJ (1985) GABA and the behavioral effects of anxiolytic drugs. Life Sci 36:1503–1513
Sawynok J (1987) GABAergic mechanisms of analgesia: An update. Pharmacol Biochem Behav 26:463–474
Scheel-Krüger J (1986) Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol Scand 73 [Suppl 107]:9–49
Sepinwall J (1985) Behavioral effects of anxiolytic agents: Possible mechanisms of action. In: Seiden LS, Balster RL (eds) Behavioral Pharmacology: The current status. Alan R. Lisss, New York, pp 181–203
Shepard RA (1986) Neurotransmitters, anxiety and benzodiazepines: A behavioral review. Neurosci Biobehav Rev 10:449–461
Shephard RA (1987) Behavioral effects of GABA agonists in relation to anxiety and benzodiazepine action. Life Sci 40:2429–2436
Shepard RA, Hamilton MS (1989) Chlordiazepoxide and valproate enhancement of saline drinking by nondeprived rats: Effects of bicuculline, picrotoxin and R015–1788. Pharmacol Biochem Behav 33:285–290
Soubrié P, De Angelis L, Simon P, Boissier JR (1976) Effects des anxiolytiques sur la prise de boisson en situation nouvelle et familiére. Psychopharmacology 50:41–45
Stutzmann JM, Bohme GA, Cochon M, Roux M, Blanchard JC (1987) Proconflict and electrocorticographic effects of drugs modulating GABAergic neurotransmission. Psychopharmacology 91:74–79
Tanganelli S, Bianchi C, Beani L (1983) Diazepam antagonizes GABA- and muscimol-reduced changes of acetylcholine release in slices of guinea-pig cerebral cortex. Naunyn-Schmiedeberg's Arch Pharmacol 324:34–37
Ticku MK, Davis WC (1981) Effect of valproic acid on [H]-diazepam and [H-dihydroxipicrotoxinin binding sites at the benzodiazepine-GABA receptor-ionophore complex. Brain Res 223:218–222
Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7
Weller CP, Ibrahim I, Sulman FG (1968) Analgesic profile of tranquilizers in multiple screening tests in mice. Arch Int Pharmacocyn Ther 176:176–192
Yunger LM, Fowler PJ, Zarevics P, Setler PE (1984) Novel inhibitors of γ-aminobutyric acid (GABA) uptake: Anticonvulsant action in rats and mice. J Pharmacol Exp Ther 228:109–115
Zorn SH, Enna SJ (1985) GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. Life Sci 37:1901–1912
Zorn SH, Willmore LJ, Bailey CM, Enna SJ (1986) A comparison of the antinociceptive and anticonvulsant effects of GABAergic drugs: Evidence for a GABA receptor system unrelated to GABA-A or GABA-B sites. In: Nistico G, Morselli PL, Lloyd KG, Fariello RG, Engel J (eds) Neurotransmitters, seizures and epilepsy III. Raven, New York, pp 123–131
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ågmo, A., Pruneda, R., Guzmán, M. et al. GABAergic drugs and conflict behavior in the rat: Lack of similarities with the actions of benzodiazepines. Naunyn-Schmiedeberg's Arch Pharmacol 344, 314–322 (1991). https://doi.org/10.1007/BF00183006
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00183006